On 24 February 2014 I was given another chance at life when almost all our hope had disappeared. Almost a month earlier, we had found out that I was not responding to my initial treatment as a Stage 4 Melanoma patient – Debrafenib and Trametinib. The cancer had spread so far and so quickly that I was given just 3 months to live.

I was given one last glimmer of hope; hope that I would gain access to a clinical trial that was about to close. The clinical trial was for an immunotherapy treatment now known as Keytruda.